PATENT CLAIM ANALYSIS

Application Number: 15882475
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-01
Patent Classification: ["514", "152000"]

Abstract:
The present invention is directed to a compound represented by Structural Formula (A): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (A) are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula (A) and its therapeutic use.

Claim (Index 7):
The compound of  claim 6 , wherein R 2  is selected from the group consisting of cyclopropyl, cyclobutyl, cyclopentyl, cyclopropylmethyl, cyclobutylmethyl, phenyl, benzyl, \u2014(CH 2 ) 2 \u2014O\u2014CH 3 , \u2014(CH 2 ) 3 \u2014OCH 3 , \u2014C(CH 3 ) 3 , \u2014CH(CH 3 ) 2 , \u2014CH 2 C(CH 3 ) 3 , \u2014CH 2 CH(CH 3 ) 2 , \u2014CH 2 \u2014CF 3 , \u2014(CH 2 ) 2 \u2014CH 2 F, and \u2014(CH 2 ) n CH 3 ; n is 0, 1, 2, 3, 4, 5 or 6; and wherein the phenyl or benzyl group represented by R 2  is optionally substituted with one or two substituents independently selected from the group consisting of (C 1 -C 4 )alkyl, halogen, (C 1 -C 4 )alkoxy, (C 1 -C 4 )alkoxy(C 1 -C 4 )alkyl, \u2014CN, halo(C 1 -C 4 )alkyl, and halo(C 1 -C 4 )alkoxy.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 86.0
- Lexical Diversity: 1.44737
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15323081', '13391407', '15296601', '15130358', '14620700']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8238176418410924
- 35 USC 102 Novelty (BERT): 0.5305165632450467
- Combined Prediction Score: 0.7944875339814879
- Mean Citation Score: 353.88025600000014
- Max Citation Score: 361.04553
- Similarity Product: 228.2329283988905

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test